Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Teva
Express Scripts
AstraZeneca
Cantor Fitzgerald
Chinese Patent Office

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,927,806

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,927,806
Title:Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
Abstract: This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer.
Inventor(s): Busse; Ursula (Saint-Louis, FR), Chypre; Camille (Annecy, FR), Fradet; Yves (Quebec, CA)
Assignee: Diagnocure Inc. (Sainte-Foy, CA)
Application Number:12/635,917
Patent Claims:see list of patent claims

Details for Patent 7,927,806

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Diagnocure Inc. (Sainte-Foy, CA) 2019-09-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Diagnocure Inc. (Sainte-Foy, CA) 2019-09-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Diagnocure Inc. (Sainte-Foy, CA) 2019-09-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
Healthtrust
Cipla
US Army
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.